Pfizer confronts ‘peak of anti-vaccination rhetoric’ as shares rebound
October 16, 2023 at 11:05 AM EDT
Cost-saving program "will touch all parts of the business" but won't affect Seagen acquisition, Pfizer says.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |